Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.
Brisson, M; EDMUNDS, WJ; Gay, NJ;
2003
Journal of medical virology, (2003).70 Sup S1 10.1002/jmv.10317.
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
Kamil, AA; Khalil, EA G; Musa, AM; Modabber, F; Mukhtar, MM; Ibrahim, ME; Zijlstra, EE; Sacks, D; SMITH, PG; Zicker, F; El-Hassan, AM;
2003
Transactions of the Royal Society of Tropical Medicine and Hygiene, (2003).97 3 10.1016/s0035-9203(03)90171-4.
Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague.
Garmory, HS; Griffin, KF; Brown, KA; Titball, RW;
2003
Vaccine, (2003).21 21-22 10.1016/s0264-410x(03)00112-9.
Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren.
Dourado, I; Rios, MH; Pereira, SM M; Cunha, SS; Ichihara, MY; Goes, JC L; RODRIGUES, LC; Bierrenbach, AL; Barreto, ML;
2003
The international journal of tuberculosis and lung disease, (2003).7 4
Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.
O'Brien, KL; Nohynek, H; World Health Organization Pneumococcal Vaccine Tri,;
2003
The Pediatric infectious disease journal, (2003).22 2 10.1097/01.inf.0000048676.93549.d1.
Use of pneumococcal polysaccharide vaccines: no simple answers.
FRENCH, N;
2003
The Journal of infection, (2003).46 2 10.1053/jinf.2002.1113.
Commentary: Non-specific effects of measles vaccine--more grist for the mill.
FINE, PE M;
2003
International journal of epidemiology, (2003).32 1 10.1093/ije/dyg031.
Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence.
MANGTANI, P; Cutts, F; Hall, AJ;
2003
The Lancet infectious diseases, (2003).3 2 10.1016/s1473-3099(03)00514-0.
More travel advice and fewer vaccinations are needed.
Hoveyda, N; BEHRENS, R;
2003
BMJ, (2003).326 7379 10.1136/bmj.326.7379.52/a.
Nature and duration of protective immunity to bluetongue virus infection.
ROY, P;
2003
Developments in biologicals, (2003).114,